MoneyWorks4Me

Alembic Pharmaceuticals informs about receipt of USFDA approval

24 Oct 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Approval for Desonide Ointment, 0.05%. The company has also submitted press release on the same. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..